EUVIMEDEUVIMED entdecken
Leitlinie

Clinical Practice Guidelines by Infectious Diseases Society of America: 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections–Selection of Antibiotic Therapy for Complicated Urinary Tract Infections

Barbara W Trautner iD, Nicolás W Cortés-Penfield, Kalpana Gupta, Elizabeth B Hirsch, Molly Horstman, Gregory J Moran, Richard Colgan, John C O'Horo, Muhammad S Ashraf, Shannon Connolly, Dimitri Drekonja, Larissa Grigoryan iD und 6 weitere

Clinical Infectious Diseases · 24.08.2026 · 82 (Supplement_3) · i36-i67

DOI: 10.1093/cid/ciaf460 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 19.12.2025. Verfasst von Barbara W Trautner und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA. Hauptthemen laut MEDLINE: Urinary Tract Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 146 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

These recommendations address the empiric choice of antibiotics in suspected complicated urinary tract infection (cUTI). Issues to balance include the need for appropriate initial empiric antimicrobial therapy, the patient's severity of illness, and antimicrobial stewardship concerns.

Methods

The panel's recommendations are based upon evidence derived from systematic literature reviews that focused on comparative benefits and harms of classes of antibiotics approved for cUTI, starting with publications from 2008 onwards, and our review of predictors of resistance in uropathogens included references identified since 2000. These recommendations adhere to a standardized methodology for rating the certainty of evidence and strength of recommendation according to the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach.

Results

The guidelines panel suggests initially selecting among preferred empiric antibiotic choices rather than alternative options, stratified for the patient's severity of illness and antimicrobial stewardship considerations. When choosing among these antibiotics for a specific patient, the guideline panel suggests a 4-step process to account for changing resistance patterns and individualized patient needs. The steps are: (1) assess the severity of illness (for initial prioritization of antibiotics), (2) consider patient-specific risk factors for resistant uropathogens (for optimization of coverage), (3) evaluate other patient-specific considerations (to reduce the risk of adverse events), and (4) for patients with sepsis, consult a relevant local antibiogram if available (to further improve the likelihood of giving appropriate empiric therapy). Lastly, the guideline panel suggests selecting definitive effective therapy with a targeted spectrum based on the result of the urine culture.

Conclusions

Many of the classes of antibiotics approved to treat cUTI demonstrate similar efficacy as other classes of antibiotics in randomized controlled trials. Bacterial resistance prevalence is always changing, and new antibiotics will be developed. In this context, the guidelines panel provides recommendations for choosing empiric antibiotic therapy for cUTI that will help clinicians decide among available antibiotic options at the point of care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract InfectionsAnti-Bacterial AgentsHumansAntimicrobial StewardshipDrug Resistance, Bacterial

Stichwörter der Autor:innen

complicated urinary tract infectionempiric antibioticsresistancesepsis

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
  • Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Section of Infectious Diseases, Boston VA Health Care System, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, Minnesota, USA.
  • Center for Innovations in Quality, Effectiveness, and Safety, Michael E. DeBakey VA Medical Center, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Clinical Emergency Medicine, David Geffen School of Medicine at UCLA, Olive View-UCLA Medical Center, Los Angeles, California, USA.

ORCID-Profile: Barbara W Trautner, Larissa Grigoryan, Anthony Schaeffer

Zitieren

APA

Trautner, B. W., Cortés-Penfield, N. W., Gupta, K., Hirsch, E. B., Horstman, M., Moran, G. J., Colgan, R., O'Horo, J. C., Ashraf, M. S., Connolly, S., Drekonja, D., Grigoryan, L., Huttner, A., Lazenby, G. B., Nicolle, L., Schaeffer, A., Yawetz, S., & Lavergne, V. (2026). Clinical Practice Guidelines by Infectious Diseases Society of America: 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections–Selection of Antibiotic Therapy for Complicated Urinary Tract Infections. Clinical Infectious Diseases, 82(Supplement_3), i36-i67. https://doi.org/10.1093/cid/ciaf460

Vancouver

Trautner BW, Cortés-Penfield NW, Gupta K, Hirsch EB, Horstman M, Moran GJ, et al. Clinical Practice Guidelines by Infectious Diseases Society of America: 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections–Selection of Antibiotic Therapy for Complicated Urinary Tract Infections. Clinical Infectious Diseases. 2026;82(Supplement_3):i36-i67. doi:10.1093/cid/ciaf460

BibTeX
@article{Trautner2026,
  author = {Trautner, Barbara W and Cortés-Penfield, Nicolás W and Gupta, Kalpana and Hirsch, Elizabeth B and Horstman, Molly and Moran, Gregory J and Colgan, Richard and O'Horo, John C and Ashraf, Muhammad S and Connolly, Shannon and Drekonja, Dimitri and Grigoryan, Larissa and Huttner, Angela and Lazenby, Gweneth B and Nicolle, Lindsay and Schaeffer, Anthony and Yawetz, Sigal and Lavergne, Valéry},
  title = {Clinical Practice Guidelines by Infectious Diseases Society of America: 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections–Selection of Antibiotic Therapy for Complicated Urinary Tract Infections},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {82},
  number = {Supplement_3},
  pages = {i36--i67},
  doi = {10.1093/cid/ciaf460}
}
Kostenlos starten →